ICON PUBLIC LIMITED
ICLR
 Delayed - 02/26 04:00:00 pm |
|
| 180.68USD | -2.04% |
Upcoming events on ICON PUBLIC LIMITED COMPANY
| 04/28/21 | Q1 2021 Earnings Release (Projected) |
| 07/28/21 | Interim 2021 Earnings Release (Projected) |
| 10/27/21 | Q3 2021 Earnings Release (Projected) |
| 02/23/22 | FY 2021 Earnings Release (Projected) |
Past events on ICON PUBLIC LIMITED COMPANY
| 02/25/21 | 09:00am | FY 2020 Earnings Call |
| 02/24/21 | 04:15pm | FY 2020 Earnings Release |
| 01/12/21 | 07:30am | JP Morgan Healthcare Conference |
| 12/16/20 | NASH US Summit |
Upcoming sector events for ICON PUBLIC LIMITED COMPANY
| 02/26/21 | 04:35pm | REGENERON PHARMACEUTICALS, INC. : American Academy of Allergy, Asthma and Immunology Virtual Meeting - Poster 010 |
| 02/26/21 | REGENERON PHARMACEUTICALS, INC. : American Academy of Allergy, Asthma and Immunology Virtual Meeting - Poster 290 |
| 02/26/21 | REGENERON PHARMACEUTICALS, INC. : American Academy of Allergy, Asthma and Immunology Virtual Meeting - Poster 447 |
| 02/26/21 | REGENERON PHARMACEUTICALS, INC. : American Academy of Allergy, Asthma and Immunology Virtual Meeting - Poster 425 |
Past sector events for ICON PUBLIC LIMITED COMPANY
| 02/25/21 | 01:40pm | GILEAD SCIENCES, INC. : SVB Leerink Global Healthcare Conference |
| 02/25/21 | 01:40pm | EXACT SCIENCES CORPORATION : SVB Leerink Global Healthcare Conference |
| 02/25/21 | IOVANCE BIOTHERAPEUTICS, INC. : FY 2020 Earnings Release |
| 02/25/21 | VIR BIOTECHNOLOGY, INC. : FY 2020 Earnings Release |
Annual results
 Previous year | Next Year |
| Annual results | 2019 | 2020 (e) | |
| Sales M $ |
Released Forecast Spread | 2 806 2 814 -0,29% | 2 788 |
| Operating income (EBITDA) M $ |
Released Forecast Spread | 495 494 0,18% | 471 |
| Operating profit (EBIT) M $ |
Released Forecast Spread | 433 433 0,15% | 403 |
| Pre-Tax Profit (EBT) M $ |
Released Forecast Spread | 427 426 0,20% | 378 |
| Net income M $ |
Released Forecast Spread | 374 374 -0,07% | 330 |
| EPS $ |
Released Forecast Spread | 6,79 6,89 -1,4% | 6,17 |
| Announcement Date | 02/19/2020 | ||
Quarterly / Semiannualy publications
| Previous period | Next period |
| Quarterly results | 2020 Q3 | 2020 Q4 (e) | |
| Sales M $ |
Released Forecast Spread | 702 661 6,1% | 750 |
| Operating income (EBITDA) M $ |
Released Forecast Spread | 125 111 13% | 130 |
| Operating profit (EBIT) M $ |
Released Forecast Spread | 108 95,0 14% | 114 |
| Pre-Tax Profit (EBT) M $ |
Released Forecast Spread | 105 92,1 14% | 111 |
| Net income M $ |
Released Forecast Spread | 91,6 81,9 12% | 97,3 |
| EPS $ |
Released Forecast Spread | 1,72 1,54 12% | 1,83 |
| Announcement Date | 10/21/2020 | ||
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise
